Allogene Therapeutics(ALLO)
$0.83-0.07 (-8.11%)
ALLO
Allogene Therapeutics earnings date
$0.83
At close:-0.07 (-8.11%)
Want to see ALLO full AI Analyst Report?
Allogene Therapeutics (ALLO) Q2 2026 Earnings Report
1,852 Followers
ALLO Q2 2026 EPS Results
- Actual EPS
- -$0.13
- Consensus EPS
- -$0.17
- Beat/Miss
- Beat by +$0.04
- One Year Ago EPS
- -$0.23
ALLO Q2 2026 Revenue Results
- Actual Revenue
- $4.64M
- Expected Revenue
- $2,000
- Beat/Miss
- Beat by +$4.64M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/12/2026
- Time
- After Close
- Conference Call
- Wednesday, August 12, 2026
ALLO Upcoming Earnings
Allogene Therapeutics's next earnings date is estimated for March 18, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
ALLO Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
ALLO Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 18, 2027 | 2026 (Q4) | -0.16- | -0.17 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.15-0.15 | -0.19 | 21.05% (+0.04) | |
| Aug 12, 2026 | 2026 (Q2) | -0.17-0.13 | -0.23 | 43.48% (+0.10) | |
| May 13, 2026 | 2026 (Q1) | -0.19-0.18 | -0.28 | 35.71% (+0.10) | |
| Mar 12, 2026 | 2025 (Q4) | -0.23-0.17 | -0.28 | 39.29% (+0.11) | |
| Nov 06, 2025 | 2025 (Q3) | -0.22-0.19 | -0.32 | 40.63% (+0.13) | |
| Aug 13, 2025 | 2025 (Q2) | -0.27-0.23 | -0.35 | 34.29% (+0.12) | |
| May 13, 2025 | 2025 (Q1) | -0.29-0.28 | -0.38 | 26.32% (+0.10) | |
| Mar 13, 2025 | 2024 (Q4) | -0.33-0.28 | -0.51 | 45.10% (+0.23) | |
| Nov 07, 2024 | 2024 (Q3) | -0.33-0.32 | -0.37 | 13.51% (+0.05) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
